Scientists work to bring about a new treatment for rare childhood cancer
In a study featured on the cover of last month's edition of the journal Cancer Cell, Anthony Faber, Ph.D., and a team of scientists demonstrated that MYCN-amplified neuroblastoma cells are highly sensitive to an investigational drug called ABT-199 that is currently being evaluated in clinical trials for another disease.
Read more here: http://medicalxpress.com/news/2016-03-scientists-treatment-rare-childhood-cancer.html